Note 3 - Net Income (Loss) Per Common Share - Basic and Diluted

9 Months Ended

Sep. 30, 2025

Notes to Financial Statements

Earnings Per Share [Text Block]

(3)       Net Income (Loss) Per Common Share - Basic and Diluted

For the three and nine months ended September 30, 2025, the Company had 26,637,500 stock options outstanding, 3,000,000 restricted stock units outstanding, and 4,063 outstanding shares of Series C redeemable convertible preferred stock (Series C Preferred Stock), each of which were not included in the computation of diluted income (loss) per common share because they would be anti-dilutive.

For the three and nine months ended September 30, 2024, the Company had 27,012,500 stock options outstanding, 5,250,000 restricted stock units outstanding, and 4,063 outstanding shares of Series C Preferred Stock, each of which were not included in the computation of diluted income (loss) per common share because they would be anti-dilutive.

The table below shows the calculation of diluted shares:

	3 Months Ended				9 Months Ended
	September 30,		September 30,		September 30,		September 30,
	2025		2024		2025		2024
Weighted average common shares outstanding - basic		528,088,472		523,138,891		526,568,064		522,028,572
Effects of dilutive shares
Stock Options		—		—		—		—
Series C Preferred Stock		—		—		—		—
Weighted average common shares outstanding - diluted		528,088,472		523,138,891		526,568,064		522,028,572

The table below summarizes common stock equivalents outstanding at September 30, 2025 and September 30, 2024:

	September 30,
	2025		2024
Stock options		26,637,500		27,012,500
Restricted Stock Units		3,000,000		5,250,000
Shares of Series C Preferred Stock		40,630,000		40,630,000
		70,267,500		72,892,500